De Rosa A - Search Results

1

Current adjuvants and new perspectives in vaccine formulation.

Montomoli E, Piccirella S, Khadang B, Mennitto E, Camerini R, De Rosa A. Montomoli E, et al. Among authors: de rosa a. Expert Rev Vaccines. 2011 Jul;10(7):1053-61. doi: 10.1586/erv.11.48. Expert Rev Vaccines. 2011. PMID: 21806399 Review.

2

Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.

Carraro G, Naso A, Montomoli E, Gasparini R, Camerini R, Panatto D, Tineo MC, De Giorgi L, Piccirella S, Khadang B, Ceracchi M, De Rosa A. Carraro G, et al. Among authors: de giorgi l, de rosa a. Vaccine. 2012 Feb 1;30(6):1170-80. doi: 10.1016/j.vaccine.2011.12.014. Epub 2011 Dec 14. Vaccine. 2012. PMID: 22178096

3

Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.

Panatto D, Amicizia D, Lai PL, Camerini R, De Rosa A, Gasparini R. Panatto D, et al. Among authors: de rosa a. J Prev Med Hyg. 2011 Sep;52(3):111-5. J Prev Med Hyg. 2011. PMID: 22010537 Review.

4

Thymosin α1 continues to show promise as an enhancer for vaccine response.

Tuthill C, Rios I, De Rosa A, Camerini R. Tuthill C, et al. Among authors: de rosa a. Ann N Y Acad Sci. 2012 Oct;1270:21-7. doi: 10.1111/j.1749-6632.2012.06680.x. Ann N Y Acad Sci. 2012. PMID: 23050813

5

Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing.

Guarnera G, DE Rosa A, Camerini R. Guarnera G, et al. Among authors: de rosa a. Ann N Y Acad Sci. 2007 Sep;1112:407-12. doi: 10.1196/annals.1415.003. Epub 2007 May 10. Ann N Y Acad Sci. 2007. PMID: 17495250 Clinical Trial.

6

Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C.

Camerini R, Ciancio A, DE Rosa A, Rizzetto M. Camerini R, et al. Among authors: de rosa a. Ann N Y Acad Sci. 2007 Sep;1112:368-74. doi: 10.1196/annals.1415.047. Epub 2007 Jun 28. Ann N Y Acad Sci. 2007. PMID: 17600286

7

Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

Ciancio A, Andreone P, Kaiser S, Mangia A, Milella M, Solà R, Pol S, Tsianos E, De Rosa A, Camerini R, McBeath R, Rizzetto M. Ciancio A, et al. Among authors: de rosa a. J Viral Hepat. 2012 Jan;19 Suppl 1:52-9. doi: 10.1111/j.1365-2893.2011.01524.x. J Viral Hepat. 2012. PMID: 22233415 Clinical Trial.

8

The effect of thymosin treatment of venous ulcers.

Guarnera G, DeRosa A, Camerini R; 8 European sites. Guarnera G, et al. Ann N Y Acad Sci. 2010 Apr;1194:207-12. doi: 10.1111/j.1749-6632.2010.05490.x. Ann N Y Acad Sci. 2010. PMID: 20536470 Clinical Trial.

9

Calcitriol plus hydrochlorothiazide prevents transient post-thyroidectomy hypocalcemia.

Testa A, Fant V, De Rosa A, Fiore GF, Grieco V, Castaldi P, Persiani R, Rausei S, D'ugo D, De Rosa G. Testa A, et al. Among authors: de rosa g, de rosa a. Horm Metab Res. 2006 Dec;38(12):821-6. doi: 10.1055/s-2006-956504. Horm Metab Res. 2006. PMID: 17163358 Clinical Trial.

10

Prevalence of HCV antibodies in autoimmune thyroid disease.

Testa A, Castaldi P, Fant V, Fiore GF, Grieco V, De Rosa A, Pazardjiklian MG, De Rosa G. Testa A, et al. Among authors: de rosa g, de rosa a. Eur Rev Med Pharmacol Sci. 2006 Jul-Aug;10(4):183-6. Eur Rev Med Pharmacol Sci. 2006. PMID: 16910348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

566 results

Search Page